Chengda Pharmaceuticals Co.,Ltd.’s Net Profit Dropped 54.8% in First Half of 2023

Chengda Pharmaceuticals Co.,Ltd. (诚达药业股份有限公司) (301201.SZ) reported a net profit of 29.4 million yuan in the first half of 2023, down 54.8% year-on-year.

Meanwhile, the company posted 166.6 million yuan in revenue, down 23.3% year-on-year.

At the end of the reporting period, it had 2.4 billion yuan in total assets and 152.9 million yuan in total liabilities, with a liability-to-asset ratio of 6.5%.